Issue 11/2015
Content (18 Articles)
Cervical cancer stem cells: opportunities and challenges
Ravindresh Chhabra
A bispecific antibody directly induces lymphoma cell death by simultaneously targeting CD20 and HLA-DR
Jing Zeng, Ran Liu, Jinjing Wang, Yi Fang
Sp1-mediated transcriptional regulation of MALAT1 plays a critical role in tumor
Shufeng Li, Qiwei Wang, Qian Qiang, Haitao Shan, Minke Shi, Baojun Chen, Sheng Zhao, Liudi Yuan
Evaluation of a bacteriochlorin-based photosensitizer’s anti-tumor effect in vitro and in vivo
Li-Jun Zhang, Donal O’Shea, Chun-Ye Zhang, Yi-Jia Yan, Li Wang, Zhi-Long Chen
Animal and cellular models of hepatocellular carcinoma bone metastasis: establishment and characterisation
Rui Hou, Yu-wei Wang, Hui-fang Liang, Zhan-guo Zhang, Zhi-min Liu, Bin-hao Zhang, Bi-xiang Zhang, Xiao-ping Chen
The prognostic impact of EGFR, ErbB2 and MET gene amplification in human gastric carcinomas as measured by quantitative Real-Time PCR
Ghasem Janbabai, Ziaeddin Oladi, Touraj Farazmandfar, Tarang Taghvaei, Farshad Naghshvar
Highlights of the Twelfth Japan–Korea Joint Symposium on Cancer and Ageing Research
Masami Suganuma, Tae Jun Park, Eisaburo Sueoka, Keisuke Iida, Yoichi Tanaka
Estrogen receptor alpha polymorphisms and the risk of prostate cancer development
Jana Jurečeková, Eva Babušíková, Monika Kmeťová, Ján Kliment, Dušan Dobrota
Downregulation of discoidin domain receptor 2 decreases tumor growth of hepatocellular carcinoma
Joong-Won Park, Yeon-Su Lee, Jin Sook Kim, Sook-Kyung Lee, Bo Hyun Kim, Jung Ahn Lee, Nam Oak Lee, Seong Hoon Kim, Eun Kyung Hong
Radiation-induced fibrosis: mechanisms and implications for therapy
Jeffrey M. Straub, Jacob New, Chase D. Hamilton, Chris Lominska, Yelizaveta Shnayder, Sufi M. Thomas
Development of second primary malignancy in patients with non-Hodgkin lymphoma: a nationwide population-based study
Sheng-Hsuan Chien, Chia-Jen Liu, Ying-Chung Hong, Chung-Jen Teng, Yu-Wen Hu, Fan-Chen Ku, Chiu-Mei Yeh, Tzeon-Jye Chiou, Jyh-Pyng Gau, Cheng-Hwai Tzeng
Evaluation of BRCA1/2 mutational status among German and Austrian women with triple-negative breast cancer
Axel Muendlein, Bettina H. Rohde, Klaus Gasser, Anton Haid, Stephanie Rauch, Elena Kinz, Heinz Drexel, Wera Hofmann, Verena Schindler, Rita Kapoor, Thomas Decker, Alois H. Lang
Stem cell mobilization and autologous stem cell transplantation after pretreatment with bendamustine, prednisone and bortezomib (BPV) in newly diagnosed multiple myeloma
Wolfram Poenisch, Madlen Plötze, Bruno Holzvogt, Marc Andrea, Thomas Schliwa, Thomas Zehrfeld, Doreen Hammerschmidt, Maik Schwarz, Thomas Edelmann, Cornelia Becker, Franz Albert Hoffmann, Andreas Schwarzer, Ute Kreibich, Kerstin Gutsche, Kolja Reifenrath, Heidrun Schwarzbach, Simone Heyn, Georg-Nikolaus Franke, Madlen Jentzsch, Sabine Leiblein, Sebastian Schwind, Thoralf Lange, Vladan Vucinic, Haifa-Katrin AlAli, Dietger Niederwieser
Overexpression of BCL2 and BAX following BFM induction therapy predicts ch-ALL patients’ poor response to treatment and short-term relapse
Lamprini Stamati, Margaritis Avgeris, Helen Kosmidis, Margarita Baka, Theodora Anastasiou, Despina Piatopoulou, Andreas Scorilas, Dimitrios Gourgiotis
Synergistic anti-tumor efficacy of doxorubicin and flavopiridol in an in vivo hepatocellular carcinoma model
Min-Sun Kwak, Su Jong Yu, Jung-Hwan Yoon, Sung-Hee Lee, Soo-Mi Lee, Jeong-Hoon Lee, Yoon Jun Kim, Hyo-Suk Lee, Chung Yong Kim
Nilotinib in patients with systemic mastocytosis: analysis of the phase 2, open-label, single-arm nilotinib registration study
Andreas Hochhaus, Michele Baccarani, Francis J. Giles, Philipp D. le Coutre, Martin C. Müller, Andreas Reiter, Helene Santanastasio, Mimi Leung, Steven Novick, Hagop M. Kantarjian
The use of targeted MR-guided prostate biopsy reduces the risk of Gleason upgrading on radical prostatectomy
Christian Arsov, Nikolaus Becker, Robert Rabenalt, Andreas Hiester, Michael Quentin, Frederic Dietzel, Gerald Antoch, Helmut E. Gabbert, Peter Albers, Lars Schimmöller
Retraction Note to: siRNA-participated chemotherapy: an efficient and specific therapeutic against gastric cancer
Donglei Zhou, Xun Jiang, Weixing Ding, Lijun Zheng, Lei Yang, Chengzhu Zheng, Liesheng Lu